UM

Browse/Search Results:  1-10 of 35 Help

Filters    
Selected(0)Clear Items/Page:    Sort:
Expression of Programmed Cell Death-Ligands in Hepatocellular Carcinoma: Correlation With Immune Microenvironment and Survival Outcomes Journal article
FRONTIERS IN ONCOLOGY, 2019,Volume: 9
Authors:  Haotian Liao;  Wen Chen;  Yunlu Dai;  Joseph J. Richardson;  Junling Guo;  Kefei Yuan;  Yong Zeng;  Kunlin Xie
Favorite  |  View/Download:40/0  |  Submit date:2020/05/12
Programmed Cell Death-ligands  Macrophage  Tumor Immune Stroma  Tumor Microenvironment  Antipd-1 Axis Therapy  Hepatocellular Carcinoma  
Engineered nano-immunopotentiators efficiently promote cancer immunotherapy for inhibiting and preventing lung metastasis of melanoma Journal article
BIOMATERIALS, 2019,Volume: 223
Authors:  Lijia Luo;  Muhammad Zubair Iqbal;  Chuang Liu;  Jie Xing;  Ozioma Udochukwu Akakuru;  Qianlan Fang;  Zihou Li;  Yunlu Dai;  Aiguo Li;  Yong Guan;  Aiguo Wu
Favorite  |  View/Download:41/0  |  Submit date:2020/05/12
Cancer Immunotherapy  Nanomaterials  Prophylactic Vaccines  Metastasis  Dendritic Cells  
Reactive versus Constitutive: Reconcile the Controversial Results about the Prognostic Value of PD-L1 Expression in cancerA Journal article
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2019,Volume: 15,Issue: 9,Page: 1933-1941
Authors:  Dapeng Hao;  Guangyu Wang;  Weiwei Yang;  Jinan Gong;  Xingmin Li;  Mingming Xiao;  Lijie He;  Li Wang;  Xiaobo Li;  Lijun Di
Favorite  |  View/Download:6/0  |  Submit date:2020/05/26
Pd-l1  Ctl  Cancer  Immunotherapy  Microenvironment  
A toll-like receptor agonist mimicking microbial signal to generate tumor-suppressive macrophages Journal article
NATURE COMMUNICATIONS, 2019
Authors:  Yanxian Feng;  Ruoyu Mu;  Zhenzhen Wang;  Panfei Xing;  Junfeng Zhang;  Lei Dong;  Chunming Wang
Favorite  |  View/Download:12/0  |  Submit date:2020/03/31
Nano-loaded natural killer cells as carriers of indocyanine green for synergetic cancer immunotherapy and phototherapy Journal article
Journal of Innovative Optical Health Sciences|, 2019,Volume: 12,Issue: 3
Authors:  Shigao Huang;  Chi Ian Fong;  Mengze Xu;  Bing-nan Han;  Zhen Yuan;  Qi Zhao
Favorite  |  View/Download:40/0  |  Submit date:2020/05/12
Nanoparticle  Nk Cell  Photothermal Therapy  Cancer Theranostics  
Building Potent Chimeric Antigen Receptor T Cells With CRISPR Genome Editing Journal article
FRONTIERS IN IMMUNOLOGY, 2019,Volume: 10
Authors:  Jie Liu;  Guangyu Zhou;  Li Zhang;  Qi Zhao
Favorite  |  View/Download:7/0  |  Submit date:2020/05/14
Chimeric Antigen Receptor  Crispr  Gene Editing  Immunotherapy  Cancer  Car t  
A Perspective Review on the Role of Nanomedicine in the Modulation of TNF-TNFR2 Axis inBreast Cancer Immunotherapy Journal article
JOURNAL OF ONCOLOGY, 2019,Volume: 2019
Authors:  Mohammad A. I. Al-Hatamleh;  Suhana Ahmad;  Jennifer C. Boer;  JitKang Lim;  Xin Chen;  Magdalena Plebanski;  Rohimah Mohamud
Favorite  |  View/Download:11/0  |  Submit date:2020/01/06
TNFR2-expressing CD4(+) Foxp3(+) regulatory T cells in cancer immunology and immunotherapy Journal article
Progress in Molecular Biology and Translational Science, 2019
Authors:  Jiang He;  Ruixin Li;  Yibo Chen;  Yuanjia Hu;  Xin Chen
Favorite  |  View/Download:20/0  |  Submit date:2019/05/08
Regulatory t Cells  Immunotherapy  Cancer  Tumor Necrosis Factor Receptor Type 2  Tumor Necrosis Factor  
FUZZY PROMETHEE ANALYSIS OF LEUKEMIA TREATMENT TECHNIQUES Journal article
WORLD CANCER RESEARCH JOURNAL, 2019,Volume: 6
Authors:  Ozsahin, I;  Ozsahin, D. Uzun;  Maisaini, M.;  Mok, G. S. P.
Favorite  |  View/Download:8/0  |  Submit date:2020/06/08
Leukemia  Therapeutic Techniques  Fuzzy Promethee  Decision-making  
Combination Strategies Using EGFR-TKi in NSCLC Therapy: Learning from the Gap between Pre-Clinical Results and Clinical Outcomes Journal article
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2018,Volume: 14,Issue: 2,Page: 204-216
Authors:  Yang, Zheng;  Tam, Kin Yip
Favorite  |  View/Download:19/0  |  Submit date:2018/10/30
Combination  Egfr-tki  Nsclc  Chemotherapy  Targeted Therapy  Immunotherapy